Johnson & Johnson plans to complete the third phase of trials of its single-dose vaccine against COVID-19 in mid-January 2021. Paul Stoffels, vice chairman of the executive committee, senior scientific expert at Johnson & Johnson said they plan to deliver to market 1 billion doses. “We are in the middle of the third phase of […]
Next year, only a small proportion of people in the European Union will be able to get the coronavirus vaccine. Officials in European countries have not yet decided on the vaccination of citizens. This was announced by Reuters on Tuesday, October 27. “By the end of 2021, there will not be enough doses of the […]
The United States plans to announce the readiness of the American vaccine against the coronavirus infection COVID-19 in the near future. The promise was made on Thursday by US President Donald Trump during the final round of election debates with the Democratic candidate Joe Biden at Belmont University in Nashville, Tennessee. This was reported by […]
Shares of Johnson & Johnson, which rose till 1.44% over the past week, on Tuesday closed with a decrease of 2.3%, despite on the publication of a better-than-expected Wall Street experts, a report for 3 fin. quarter. Investors are concerned about the potential consequences of ending the large-scale study of the J&J vaccine against COVID-19, […]
Shares of the Johnson & Johnson may slow because the last stimulus to it was the company’s transition to the final clinical trial of the vaccine against COVID-19 on September 23, after which the shares rose by more than 5%. However, as of Tuesday, before the opening of trading, the price of J&J shares did […]
Half of the 2 billion doses of coronavirus vaccine that the American company Novavax intends to develop, will be manufactured at its Czech plant Praha Vaccines, said on Tuesday at a press conference the Prime Minister of the Czech Republic Andrej Babiš, who visited this enterprise near Prague. “Novavax wants to produce 2 billion coronavirus […]
Johnson & Johnson was one of the first companies to devote large resources to the fight against COVID-19 and vaccine development, and was one of the first to receive support from the US government. However, J&J is not currently one of the companies, who conducting clinical trials of its final vaccine candidates COVID-19 in humans. […]